Broqueza, J.; Prabaharan, C.B.; Allen, K.J.H.; Jiao, R.; Fisher, D.R.; Dickinson, R.; MacDonald-Dickinson, V.; Uppalapati, M.; Dadachova, E.
Radioimmunotherapy Targeting IGF2R on Canine-Patient-Derived Osteosarcoma Tumors in Mice and Radiation Dosimetry in Canine and Pediatric Models. Pharmaceuticals 2022, 15, 10.
https://doi.org/10.3390/ph15010010
AMA Style
Broqueza J, Prabaharan CB, Allen KJH, Jiao R, Fisher DR, Dickinson R, MacDonald-Dickinson V, Uppalapati M, Dadachova E.
Radioimmunotherapy Targeting IGF2R on Canine-Patient-Derived Osteosarcoma Tumors in Mice and Radiation Dosimetry in Canine and Pediatric Models. Pharmaceuticals. 2022; 15(1):10.
https://doi.org/10.3390/ph15010010
Chicago/Turabian Style
Broqueza, Jaline, Chandra B. Prabaharan, Kevin J. H. Allen, Rubin Jiao, Darrell R. Fisher, Ryan Dickinson, Valerie MacDonald-Dickinson, Maruti Uppalapati, and Ekaterina Dadachova.
2022. "Radioimmunotherapy Targeting IGF2R on Canine-Patient-Derived Osteosarcoma Tumors in Mice and Radiation Dosimetry in Canine and Pediatric Models" Pharmaceuticals 15, no. 1: 10.
https://doi.org/10.3390/ph15010010
APA Style
Broqueza, J., Prabaharan, C. B., Allen, K. J. H., Jiao, R., Fisher, D. R., Dickinson, R., MacDonald-Dickinson, V., Uppalapati, M., & Dadachova, E.
(2022). Radioimmunotherapy Targeting IGF2R on Canine-Patient-Derived Osteosarcoma Tumors in Mice and Radiation Dosimetry in Canine and Pediatric Models. Pharmaceuticals, 15(1), 10.
https://doi.org/10.3390/ph15010010